Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy improves diagnosis and treatment planning for trichostasis spinulosa.

Three Iranian men had reddish-brown facial pigmentation with no effective treatment.

TPA is about 50 times more effective at promoting tumors than MZ.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.

Triamcinolone regrows hair better but relapses more than anthralin.

A unique hair tumor with a rippled pattern was identified, showing incomplete differentiation and unusual cell arrangements.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Trichoblastic carcinoma may be a distinct type of skin cancer different from basal cell carcinoma.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Mutations in TBX3 cause horses to have more even hair color instead of Dun camouflage.

The authors suggest using a standard system to name hair grafts to improve communication in hair restoration.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Tislelizumab can cause cutaneous lupus erythematosus.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.